What factor is NOT involved in making late-stage clinical trials more difficult to conduct?
A. Patient enrollment criteria is becoming increasingly difficult to satisfy B. Multiple trials in the same therapeutic area compete for the same sites/investigators/patients C. The sponsor organizations have difficulty funding late stage trials if they are not FDA mandated. D. The FDA demands an increased number of participants